Superficial, Palpable, Unresectable/Metastatic Solid Tumour

Explore clinical trials studying Superficial, Palpable, Unresectable/Metastatic Solid Tumour. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Superficial, Palpable, Unresectable/Metastatic Solid Tumour trial results

Completed

Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour

NCT03593226

Conditions: Superficial, Palpable, Unresectable/Metastatic Solid Tumour
Locations: UCLA Los Angeles, California, United States

AHS Hospital Corp. Morristown, New Jersey, United States

Providence Cancer Institute Franz Clinic Portland, Oregon, United States

Emek Medical Center Afula, Israel

View all 14 locations

View Trial Details